(Q49083717)

18 February 2018

title

Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma. (English)

1 reference

18 February 2018

1 reference

fluticasone propionate

1 reference

Derom E

1

1 reference

18 February 2018

Van Schoor J

2

1 reference

18 February 2018

Verhaeghe W

3

1 reference

18 February 2018

Vincken W

4

1 reference

18 February 2018

Pauwels R

5

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

18 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

18 February 2018

volume

160

1 reference

18 February 2018

issue

1

1 reference

18 February 2018

page(s)

157-161

1 reference

18 February 2018

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Purpura and dermal thinning associated with high dose inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Assessment of the relative systemic potency of inhaled fluticasone and budesonide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

The effect of an inhaled steroid on the hypothalamic-pituitary-adrenal axis--which tests should be used?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

New perspectives on inhaled drug delivery and systemic bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Binding kinetics of fluticasone propionate to the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9805106

10.1164/AJRCCM.160.1.9805106

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018